Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA

SIMPLE SUMMARY: Differentiation therapy is one of the most promising treatment approaches for radioiodine refractory papillary thyroid cancer (RR-PTC). In this study, we found that insulin-like growth factor 2 mRNA-binding protein 2 promoted dedifferentiation of PTC via integrating to 3′-untranslate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sa, Ri, Liang, Rui, Qiu, Xian, He, Ziyan, Liu, Zhiyan, Chen, Libo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909796/
https://www.ncbi.nlm.nih.gov/pubmed/35267576
http://dx.doi.org/10.3390/cancers14051268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909796/
https://www.ncbi.nlm.nih.gov/pubmed/35267576
http://dx.doi.org/10.3390/cancers14051268

Ejemplares similares